Guillain-Barré Syndrome Linked to the RSV Vaccine
The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]
More Than 1,000 Adverse Reactions to COVID Shots Reported in New Brunswick, Canada
According to the Department of Health in New Brunswick, Canada, 1,148 people living in that province suffered an adverse reaction after receiving a COVID-19 shot between Dec. 14, 2020 and Jan. 14, 2023. It was reported that 313 of the reactions were considered “serious.”1 Health Canada, the department of the Canadian government responsible for national health […]
CDC, FDA Find Possible Link Between Pfizer’s Bivalent COVID Shot and Strokes
The U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) said last week that they are investigating a possible link between Pfizer/BioNTech’s bivalent messenger RNA (mRNA) Comirnaty COVID biologic and an increased risk of a type of ischemic stroke among people 65 years of age and older. Data from the […]
Another Study Confirms COVID Vaccine Alters Menstrual Cycles
A study published in the BMJ Medicine in August 2022 involving almost 20,000 women found an association between those who received a COVID-19 shot and an increased length in menstrual cycles. Of the 15,000 vaccinated women in the study, two-thirds received Pfizer/BioNTech’s COVID messenger RNA (mRNA) biologic, but the data also included women who received […]
South Africa Confirms Second Guillain-Barré Syndrome Death Due to COVID Vaccine
The South African Health Products Regulatory Authority (SAHPRA) confirmed on Sept. 12, 2022 that another person in South Africa has died of a polio-like neurological disorder that causes paralysis known as Guillain-Barré syndrome (GBS) due to receiving Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S COVID-19 vaccine. SAHPRA said the National Immunization Safety Expert Committee (NISEC) performed […]
German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions
Techniker Krankenkasse, Germany’s largest health insurance company, reported that 437,593 of 11 million (1 in 25) insured individuals in 2021 had to undergo medical treatment as a result of adverse reactions from COVID-19 shots.1 COVID shots currently approved for use in Germany include Novavax’s Nuvaxovid, Moderna’s Spikevax, Pfizer/BioNTech’s Comirnaty, Johnson & Johnson/Janssen’s Ad26.COV2.S, AstraZeneca/Oxford University’s […]
